Luc Even

USPTO Granted Patents = 16 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 228(Granted Patents)

Location History:

Antony, FR (2012)
Paris, FR (1996 - 2014)

Company Filing History:

Years Active: 1996-2014

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8835418 - Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application (2014-09-16),

2. 8697883 - Cyclopenta[C]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof (2014-04-15),

3. 8680096 - Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators (2014-03-25),

4. 8618301 - 5-phenylpyrazolopyridine derivatives, preparation and therapeutic use thereof (2013-12-31),

5. 8546424 - Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof (2013-10-01),

6. 8288376 - [object Object] (2012-10-16),

7. 8143248 - Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use (2012-03-27),

8. 8080547 - Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof (2011-12-20),

9. 7863279 - Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof (2011-01-04),

10. 7781477 - [object Object] (2010-08-24),

11. 7582671 - Therapeutic use of N-(1H-indolyl)-1H-indole-2-carboxamide derivatives (2009-09-01),

12. 7384969 - N-(1H-indolyl)-1H-indole-2-carboxamide derivatives, their preparation and their therapeutic use (2008-06-10),

13. 6635645 - 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses (2003-10-21),

14. 6407095 - 1,4-diazabicylo[3,2,2]nonane derivatives, their preparation and their therapeutic application (2002-06-18),

15. 6140335 - Use of mizolastine for treating inflammatory diseases associated with (2000-10-31),

Title: Luc Even: Innovator in Therapeutic Applications

Introduction

Luc Even is a prominent inventor based in Paris, France. He has made significant contributions to the field of therapeutic applications, holding a total of 16 patents. His work focuses on innovative chemical compounds that have potential medical uses.

Latest Patents

Among his latest patents are the "Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application." This patent discloses hexafluoroisopropyl carbamate derivatives of a specific general formula. Another notable patent is for "Cyclopenta[C]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof," which relates to the preparation and therapeutic applications of cyclopenta[c]pyrrole-2-carboxylate derivatives.

Career Highlights

Luc Even has worked with notable companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas in therapeutic applications.

Collaborations

Throughout his career, Luc has collaborated with esteemed colleagues such as Laurent Dubois and Yannick Evanno. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Luc Even is a distinguished inventor whose work in therapeutic applications has led to multiple patents and significant advancements in the field. His innovative contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.